Xiaowu Chen
21Patents
13h-index
70Co-inventors
84Inventor score
Filing activity: Mar 30, 1995 → May 6, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7452901B2 | Anti-cancer phosphonate analogs | Chemistry; Metallurgy | 69 | Expired |
| US7645747B2 | Therapeutic phosphonate compounds | Chemistry; Metallurgy | 57 | Expired |
| US8022083B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 44 | Active |
| US8871785B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 33 | Active |
| US7462608B2 | Non nucleoside reverse transcriptase inhibitors | Physics | 29 | Expired |
| US7417055B2 | Kinase inhibitory phosphonate analogs | Chemistry; Metallurgy | 28 | Expired |
| US7407965B2 | Phosphonate analogs for treating metabolic diseases | Human Necessities | 26 | Expired |
| US9139604B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 26 | Active |
| US7429565B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 24 | Expired |
| US7432261B2 | Anti-inflammatory phosphonate compounds | Chemistry; Metallurgy | 23 | Expired |
| US7470724B2 | Phosphonate compounds having immuno-modulatory activity | Human Necessities | 23 | Expired |
| US7427636B2 | Inosine monophosphate dehydrogenase inhibitory phosphonate compounds | Chemistry; Metallurgy | 21 | Expired |
| US7649015B2 | Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds | Physics | 14 | Expired |
| US7253180B2 | Pre-organized tricyclic integrase inhibitor compounds | Chemistry; Metallurgy | 12 | Expired |
| US7427624B2 | Purine nucleoside phosphorylase inhibitory phosphonate compounds | Human Necessities | 11 | Expired |
| US10035809B2 | Substituted 2,3,4,5,7,9,13,13a-octahydro-1,5-methanopyrido[1′,2′:4,5]pyrazino[1,2-a][1,3]diazepines and methods for treating viral infections | Chemistry; Metallurgy | 9 | Active |
| US6194421A | Inhibitors of metazoan parasite proteases | Emerging Cross-Sectional Technologies | 4 | Expired |
| US8987250B2 | Therapeutic compounds | Chemistry; Metallurgy | 3 | Active |
| US10689399B2 | Substituted 3,4,5,6,8,10,14,14a-octahydro-2h-2,6-methanopyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazocines and methods for treating viral infections | Chemistry; Metallurgy | 2 | Active |
| US5739170A | Inhibitors of metazoan parasite proteases | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11548901B2 | Substituted 1,4-methanopyrido[1′,2′:4,5]pyrazino[1,2-a]pyrimidines for treating viral infections | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.